SOURCE: Implant Sciences Corporation

Implant Sciences Corporation

March 06, 2012 07:00 ET

Implant Sciences Joins SOSSEC - Consortium of Leaders in Security & Defense Technologies

Opportunity to Work Collaboratively With the US Army

WILMINGTON, MA--(Marketwire - Mar 6, 2012) - Implant Sciences Corporation (OTCQB: IMSC) (PINKSHEETS: IMSC), a high technology supplier of systems and sensors for homeland security markets, announced today that it has become a member of System of Systems Security (SOSSEC) Consortium, a key defense and security industry consortium. SOSSEC's purpose is to assist Consortium members, such as Implant Sciences, in meeting the US Army's mission requirement to provide decisive and effective support in response to natural and man-made threats to the nation and its military forces.

SOSSEC enjoys a special working arrangement with the US Army's Armament Research, Development and Engineering Center (ARDEC), which recognizes the Consortium as a provider of R&D for Homeland Defense programs for the next five years. Implant Sciences, along with other Consortium members, will receive the support of SOSSEC in business development, contracting, invoicing, product delivery, and interfacing with the US Department of Defense. The prime technology and deployment focus of SOSSEC is in Homeland Security solutions, force protection, and critical infrastructure protection.

"As a member of SOSSEC we will be working jointly with the companies, thought leaders, and technology developers who are shaping the future of security solutions for defense. The Consortium works closely with the US government to accelerate the development of critical new technologies into deployable products," stated Glenn D. Bolduc, President and CEO of Implant Sciences. "This is an opportunity for us to work directly with the US military to provide our explosives trace detection equipment, while continuing to develop next-generation technologies to meet our nation's defense needs."

About SOSSEC
The SOSSEC Consortium was formed in response to a US Army's mission requirement to provide decisive and effective support in response to the natural and man-made threats to the nation and its military forces. The capabilities created under this Consortium are, thereby, directly applicable to the full spectrum of national security and disaster response missions. For more information please visit: http://www.sossecconsortium.com.

About the Quantum Sniffer™ QS-H150
The QS-H150 is a handheld explosives trace detector that uses Ion Mobility Spectrometry (IMS) to rapidly detect and identify trace amounts of a wide variety of military, commercial, and homemade explosives. The QS-H150 uses no radioactive materials and features a low-maintenance design that is self-calibrating and self-clearing, providing very high levels of operational availability.

About the Quantum Sniffer™ QS-B220
The QS-B220, introduced in May 2011, is a benchtop explosives and narcotics trace detector that uses Ion Mobility Spectrometry (IMS) to rapidly detect and identify trace amounts of a wide variety of military, commercial, and homemade explosives, plus narcotic substances. The QS-B220 continues the Implant Sciences tradition of freedom from radioactive materials, low total cost of ownership, and high operational availability.

About Implant Sciences
Implant Sciences develops, manufactures, and sells sophisticated sensors and systems for Security, Safety, and Defense (SS&D) markets. The Company has developed innovative proprietary technologies used in its explosives and narcotics trace detection systems, which ship to a growing number of locations domestically and internationally. Implant Sciences products have been deployed in a wide range of security environments including airports, subways, railways, cargo facilities, nuclear power plants, police departments, military units, government buildings, and financial institutions. The QS-H150 and QS-B220 are Department of Homeland Security (DHS) Qualified Anti-Terrorism Technologies under the Support Anti-terrorism by Fostering Effective Technology Act of 2002 (the SAFETY Act). For further details on the Company and its products, please visit the Company's website at www.implantsciences.com.

Safe Harbor Statement
This press release may contain certain "forward-looking statements," as that term is defined in the Private Securities Litigation Reform Act of 1995. Such statements are based on management's current expectations and are subject to risks and uncertainties that could cause the Company's actual results to differ materially from the forward-looking statements. Such risks and uncertainties include, but are not limited to, the risks that our explosives detection products and technologies (including any new products we may develop) may not be accepted by the Transportation Security Administration or by other U.S. or foreign government and law enforcement agencies or commercial consumers of security products; economic, political and other risks associated with international sales and operations could adversely affect our sales; our business is subject to intense competition and rapid technological change; and other risks and uncertainties described in our filings with the Securities and Exchange Commission, including our most recent Forms 10-K, 10-Q and 8-K. Such statements are based on management's current expectations and assumptions which could differ materially from the forward-looking statements.

Contact Information

  • Contact:
    Implant Sciences Corporation
    Company Contact:
    Glenn Bolduc
    CEO
    978-752-1700
    Email Contact

    or

    Investor Contact:
    Laurel Moody
    646-810-0608
    Email Contact